Foreign-Trade Zone (FTZ) 7-Mayaguez, Puerto Rico; Authorization of Production Activity; Lilly del Caribe, Inc. (Pharmaceutical Products); Carolina, Puerto Rico
---
identifier: "/us/fr/2020-17992"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Foreign-Trade Zone (FTZ) 7-Mayaguez, Puerto Rico; Authorization of Production Activity; Lilly del Caribe, Inc. (Pharmaceutical Products); Carolina, Puerto Rico"
title_number: 0
title_name: "Federal Register"
section_number: "2020-17992"
section_name: "Foreign-Trade Zone (FTZ) 7-Mayaguez, Puerto Rico; Authorization of Production Activity; Lilly del Caribe, Inc. (Pharmaceutical Products); Carolina, Puerto Rico"
positive_law: false
currency: "2020-08-18"
last_updated: "2020-08-18"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Commerce Department"
document_number: "2020-17992"
document_type: "notice"
publication_date: "2020-08-18"
agencies:
- "Commerce Department"
- "Foreign-Trade Zones Board"
fr_citation: "85 FR 50803"
fr_volume: 85
docket_ids:
- "B-23-2020"
---
# Foreign-Trade Zone (FTZ) 7—Mayaguez, Puerto Rico; Authorization of Production Activity; Lilly del Caribe, Inc. (Pharmaceutical Products); Carolina, Puerto Rico
On April 14, 2020, Lilly del Caribe, Inc., submitted a notification of proposed production activity to the FTZ Board for its facility within Subzone 7K, in Carolina, Puerto Rico.
The notification was processed in accordance with the regulations of the FTZ Board (15 CFR part 400), including notice in the *Federal Register* inviting public comment (85 FR 23505-23506, April 28, 2020). On August 12, 2020, the applicant was notified of the FTZ Board's decision that no further review of the activity is warranted at this time. The production activity described in the notification was authorized, subject to the FTZ Act and the FTZ Board's regulations, including Section 400.14.
Dated: August 12, 2020.
Andrew McGilvray,
Executive Secretary.